Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
RESEARCH TOOLSreports
Holding APVO?
Track your performance easily
APVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.14 - $10.80
Previous Close$0.27
Volume596.97K
Average Volume (3M)6.71M
Market Cap
$4.85M
Enterprise Value$1.99M
Total Cash (Recent Filing)$7.75M
Total Debt (Recent Filing)$4.80M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Mar 26, 2025EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-25.45
Shares Outstanding18,512,084
10 Day Avg. Volume3,350,095
30 Day Avg. Volume6,709,163
Standard Deviation0.79
R-Squared0.11
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)1.21
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.08
Forecast
1Y Price Target
$8.00Price Target Upside2953.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Aptevo Therapeutics News
Ownership Overview
0.26% Insiders
0.12% Mutual Funds
5.28% Other Institutional Investors
94.33% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
APVO FAQ
What was Aptevo Therapeutics Inc’s price range in the past 12 months?
Aptevo Therapeutics Inc lowest stock price was $0.14 and its highest was $10.80 in the past 12 months.
What is Aptevo Therapeutics Inc’s market cap?
Currently, no data Available
When is Aptevo Therapeutics Inc’s upcoming earnings report date?
Aptevo Therapeutics Inc’s upcoming earnings report date is Mar 26, 2025 which is in 124 days.
How were Aptevo Therapeutics Inc’s earnings last quarter?
Aptevo Therapeutics Inc released its earnings results on Nov 07, 2024. The company reported -$0.48 earnings per share for the quarter, beating the consensus estimate of -$0.57 by $0.09.
Is Aptevo Therapeutics Inc overvalued?
According to Wall Street analysts Aptevo Therapeutics Inc’s price is currently Undervalued.
Does Aptevo Therapeutics Inc pay dividends?
Aptevo Therapeutics Inc does not currently pay dividends.
What is Aptevo Therapeutics Inc’s EPS estimate?
Aptevo Therapeutics Inc’s EPS estimate is -$0.28.
How many shares outstanding does Aptevo Therapeutics Inc have?
Aptevo Therapeutics Inc has 18,512,083 shares outstanding.
What happened to Aptevo Therapeutics Inc’s price movement after its last earnings report?
Aptevo Therapeutics Inc reported an EPS of -$0.48 in its last earnings report, beating expectations of -$0.57. Following the earnings report the stock price went up 19.231%.
Which hedge fund is a major shareholder of Aptevo Therapeutics Inc?
Currently, no hedge funds are holding shares in APVO
---
Aptevo Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (2953.44% Upside)
$8.00 (2953.44% Upside)
Blogger Sentiment
Bullish
APVO Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 10.9%
Last 30 Days ▲ 10.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-96.91%
12-Months-Change
Fundamentals
Return on Equity
-250.96%
Trailing 12-Months
Asset Growth
-44.17%
Trailing 12-Months
Company Description
Aptevo Therapeutics Inc
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
---
APVO Stock 12 Month Forecast
Average Price Target
$8.00
▲(2953.44% Upside)
Technical Analysis
ADMA Biologics
―
TuHURA Biosciences
―
TRACON Pharmaceuticals
―
Pieris Pharmaceuticals
―
Best Analysts Covering APVO
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-48.70%
reiterated a buy rating 2 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -48.70% per trade.
---